Choline alfostserat | Cerepro solution for iv. and w / mouse. enter 250 mg / ml 4 ml ampoules 3 pcs.

Release form

Solution for intravenous and intramuscular administration

Packing

3 ampoules of 4 ml.

Indications

Acute and recovery periods of severe head injury and ischemic stroke, recovery period of hemorrhagic stroke, occurring with focal hemispheric symptoms or symptoms of damage to the brain stem

psycho-organic syndrome against the background of degenerative and involutional changes in the brain

chronic cerebrovascular insufficiency

cognitive disorders (impaired mental function, memory, confusion, disorientation, decreased motivation, initiative and ability to concentrate) including with dementia and encephalopathy

senile pseudomelancholy.

Contraindications

hypersensitivity

pregnancy

breastfeeding.

Special instructions

If you experience nausea after taking the drug, you should reduce the dose.

Cerepro has no effect on the speed of psychomotor reactions.

Composition of

1 ml contains:

active substance:

glycerylphosphorylcholine hydrate 250 mg,

excipients:

water for injection

Dosage and administration of

In acute conditions: intramuscularly or intravenously (slowly) at 1.0 g (1 ampoule) per day for 10-15 days, then go on to take capsules orally at 0.8 g (2 capsules) in the morning and 0.4 g (1 capsule) during the day for 6 months.

Side effects

Allergic reactions, nausea (due to dopaminergic activation).

Storage conditions

In the dark place at a temperature of 2-25 РC.

active substance

Choline alphosceratus

Terms and conditions

prescription

Dosage form

solution for injection and infusions

Veropharm, Russia